drugset / Trial / NCT00882804

Hemin in Healthy Subjects

NCT00882804 ↗

Phase 1 Completed 10 enrolled Mayo Clinic
RandomizedParallel-groupTriple-blind

Summary

This study is being done because we want to learn if hemin can increase the production of heme oxygenase 1. Heme oxygenase 1 (HO-1) is an enzyme which protects cells from physical, chemical, and biologic stress. Hemin is produced from red blood cells and is approved by the Food and Drug Administration for treating acute porphyria, which is an inherited condition caused by an enzyme deficiency.

Timeline

Start
2009-02
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Hemin Unknown 3 mg/kg Intravenous

Indications

No indication recorded.